In vitro and in vivo evaluation of elephant P53 (EP53) protein nanoparticles for pediatric osteosarcoma
Ended Project Grant Awarded Last action
- Award ID
- R41CA221653
- Recipient
-
Peel Therapeutics Inc. UEI G1X8J9LJZM78
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,465
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Utah, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $300,465 |
Quick answers
Who received award R41CA221653?
R41CA221653 was awarded to Peel Therapeutics Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2018.
How much is award R41CA221653 worth?
$300,465 has been obligated on R41CA221653.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award